A landmark preclinical study has unveiled a novel gene therapy designed to neutralize chronic pain at its source within the…
Read More
AbbVie Secures Up to $745 Million in Pain Pipeline Deal with Chinese Biopharma Haisco
AbbVie, a global biopharmaceutical giant, has finalized a significant strategic collaboration with Haisco Pharmaceutical Group, a prominent Chinese biopharmaceutical company.…
Read More
Penn Researchers Develop Breakthrough Non-Addictive Gene Therapy Targeting Brain Pain Circuits to Combat Chronic Pain and Opioid Crisis
A new preclinical study has identified a gene therapy that directly targets pain-processing areas in the brain while avoiding the…
Read More
Gene Therapy Breakthrough Offers Non-Addictive Path for Chronic Pain Treatment via Brain-Specific Circuit Targeting
A groundbreaking preclinical study has identified a novel gene therapy that directly targets pain-processing regions within the brain, potentially revolutionizing…
Read MoreYOU MAY HAVE MISSED
